Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street Consumer Discretionary Select Sector SPDR ETF
XLY
|
+$1.04B |
| 2 |
State Street Industrial Select Sector SPDR ETF
XLI
|
+$753M |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$717M |
| 4 |
State Street Health Care Select Sector SPDR ETF
XLV
|
+$653M |
| 5 |
Microsoft
MSFT
|
+$421M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street Consumer Staples Select Sector SPDR ETF
XLP
|
+$380M |
| 2 |
STJ
St Jude Medical
STJ
|
+$235M |
| 3 |
JPMorgan Chase
JPM
|
+$211M |
| 4 |
LLTC
Linear Technology Corp
LLTC
|
+$175M |
| 5 |
iShares China Large-Cap ETF
FXI
|
+$141M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 5.74% |
| 2 | Healthcare | 5.25% |
| 3 | Financials | 4.26% |
| 4 | Communication Services | 3.9% |
| 5 | Consumer Discretionary | 3.37% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
CRR
5701
PUT
DELISTED
Carbo Ceramics Inc.
CRR
| $21K | ﹤0.01% |
1,600
-29,300
| -95% | -$375K |
|
|
FRED
5702
PUT
DELISTED
Fred's Inc
FRED
| $21K | ﹤0.01% |
+1,600
| New | +$25.2K |
|
|
CCC
5703
DELISTED
Calgon Carbon Corp
CCC
| $21K | ﹤0.01% |
1,486
-9,591
| -87% | -$147K |
|
|
MACK
5704
DELISTED
Merrimack Pharmaceuticals, Inc.
MACK
| $21K | ﹤0.01% |
864
-6,624
| -88% | -$166K |
|
|
KEG
5705
DELISTED
Key Energy Services, Inc. Common Stock
KEG
| $21K | ﹤0.01% |
+900
| New | +$27.6K |
|
|
RBS.PRL.CL
5706
DELISTED
Royal Bank Of Scotland Group Plc
RBS.PRL.CL
| $21K | ﹤0.01% |
850
| – | – |
|
5707
Badger Meter
BMI
$3.89B
| $20K | ﹤0.01% |
541
-4,167
| -89% | -$153K |
|
5708
Cass Information Systems
CASS
$714M
| $20K | ﹤0.01% |
414
-307
| -43% | -$15.4K |
|
5709
CALL
Invesco DB Base Metals Fund
DBB
$312M
| $20K | ﹤0.01% |
1,200
-400
| -25% | -$6.45K |
|
5710
CALL
DTE Energy
DTE
$29.5B
| $20K | ﹤0.01% |
235
-3,055
| -93% | -$259K |
|
5711
PUT
Flotek Industries
FTK
$852M
| $20K | ﹤0.01% |
267
-100
| -27% | -$6.85K |
|
5712
Global Industrial
GIC
$1.37B
| $20K | ﹤0.01% |
1,754
+1,650
| +1,587% | +$14K |
|
5713
IAMGOLD
IAG
$8.2B
| $20K | ﹤0.01% |
5,082
-406,697
| -99% | -$1.73M |
|
5714
CALL
Intrepid Potash
IPI
$456M
| $20K | ﹤0.01% |
1,150
+130
| +13% | +$2.51K |
|
|
NAK
5715
Northern Dynasty Minerals
NAK
$784M
| $20K | ﹤0.01% |
+14,424
| New | +$29.6K |
|
5716
CALL
PG&E
PCG
$38.3B
| $20K | ﹤0.01% |
300
-500
| -63% | -$31.9K |
|
5717
PUT
PRA Group
PRAA
$663M
| $20K | ﹤0.01% |
600
| – | – |
|
5718
CALL
Protolabs
PRLB
$1.79B
| $20K | ﹤0.01% |
+400
| New | +$21.2K |
|
5719
Protagonist Therapeutics
PTGX
$8.79B
| $20K | ﹤0.01% |
1,635
+1,417
| +650% | +$22.8K |
|
5720
CALL
RPC Inc
RES
$1.24B
| $20K | ﹤0.01% |
1,100
+200
| +22% | +$4.04K |
|
|
SOHU
5721
CALL
Sohu.com
SOHU
$362M
| $20K | ﹤0.01% |
500
-1,300
| -72% | -$52.1K |
|
5722
UNIFI
UFI
$119M
| $20K | ﹤0.01% |
712
-2,322
| -77% | -$66.4K |
|
5723
CALL
Vornado Realty Trust
VNO
$7.41B
| $20K | ﹤0.01% |
247
-147,946
| -100% | -$12.6M |
|
5724
XBiotech
XBIT
$68M
| $20K | ﹤0.01% |
1,168
-1,056
| -47% | -$13.8K |
|
|
HTLF
5725
DELISTED
Heartland Financial USA, Inc.
HTLF
| $20K | ﹤0.01% |
425
-824
| -66% | -$39.7K |
|
Similar funds
Barclays's Q1 2017 Portfolio in Review
As of Q1 2017, Barclays held 7,315 positions worth $91.9B, down 0.67% from $92.5B the previous quarter. Its ten largest holdings account for 34% of the portfolio.
Barclays withdrew a net $6.3B in Q1 2017, closing 393 positions and reducing 3,105 holdings. Its most notable exit was St Jude Medical, an estimated $235M position sold in full.
By sector, the portfolio is most concentrated in Technology at 5.7% of assets, up from 4.7% a quarter earlier, followed by Healthcare and Financials.
Against the trend, Barclays opened a new position in iPath S&P VEQTOR ETN worth $95.8M.
- Barclays's largest Q1 2017 buy was iPath S&P VEQTOR ETN: 670,000 shares worth $95.8M.
- Barclays added most to State Street Consumer Discretionary Select Sector SPDR ETF in Q1 2017, an estimated $1.04B increase.
- Barclays's biggest Q1 2017 reduction was State Street Consumer Staples Select Sector SPDR ETF, cutting an estimated $380M.
- Barclays fully exited St Jude Medical in Q1 2017, selling an estimated $235M.
- Barclays's ten largest holdings make up 34% of its $91.9B portfolio in Q1 2017.
- Barclays opened 572 new positions and closed 393 in Q1 2017.
- Barclays's portfolio value fell 0.67% quarter-over-quarter to $91.9B.
Based on Barclays's 13F filing for Q1 2017, filed 15 May 2017.